home All News open_in_new Full Article
China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms?
today 2 d. ago attach_file Events
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Events
3 d. ago
Yarrow blooms with $1.37B deal, landing autoimmune thyroid disease drug from China’s GenSci
attach_file
Economics
attach_file
Events
attach_file
Events
attach_file
Economics
attach_file
Events
attach_file
Society
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Events
ID: 3516317502